secondary outcome measures

(redirected from secondary outcome variables)

secondary outcome measures

The outcome measures in a clinical trial that provide information on therapeutic effects of secondary importance, side effects or tolerability. Data on secondary outcomes are used to evaluate additional effects of the intervention not included in the primary outcome measure.
References in periodicals archive ?
Results of study also demonstrated reduction in waist and hip circumference, positive change in diet behavior by limiting fat intake, energy dense food and increase intake of fruits as secondary outcome variables. These findings support previous evidence from experiences of the region that there is scope for improving dietary behavior through nutritional education andthese proved effective in bringing change in anthropometric variables and reducing risk of chronic diseases associated with obesity12,13.
Descriptive qualities and a comparison of the primary outcome variables and secondary outcome variables in children with acute gastroenteritis in each group is summarized in Table 2.
Table 2: Descriptive qualities and comparison of primary and secondary outcome variables in the two groups.
The secondary outcome variables were need for oxytocin, indication for caesarean section, and mode of delivery.
Significant drug-placebo differences were found for most secondary outcome variables with no major differences between AD and VaD subgroups.
An analysis of secondary outcome variables showed that women in the control group received more antibiotic doses postpartum than women in the study group (17.7 versus 3.7) and during the intrapartum and postpartum period combined (20.7 versus 6.2).
The primary outcome variables are cardiac death, myocardial infarction, and hospitalization; secondary outcome variables include total mortality, exercise tolerability, and quality of life.
The placebo group showed no statistically significant change from baseline for any of the secondary outcome variables. For patients treated with pergolide, however, the PLMSs decreased from 48.9 per hour to 14.5 per hour (P <.001) and the duration of RLS symptoms decreased from 7.0 hours per day to 1.8 hours per day (P = .036).